influenza

Codagenix scores big with $20M Series B round

By GREGORY ZELLER // A stellar $20 million investment round has blasted a Long Island biotech into the stratosphere, and a new tax bracket. Farmingdale-based Codagenix Inc., a 2012 startup launched by Stony Brook University assistant research professor Steffan Mueller and Farmingdale State College biology professor J. Robert Coleman, has closed a $20 million Series B investment round, led by Adjuvant Capital, a New York City/San Francisco venture capital firm focused on life sciences. Also…


Survey: One-third of flu victims still come to work

By GREGORY ZELLER // Workmates making you sick? You don’t know the half of it. One-third of workers who have the flu still report to work, according to a new public health survey circulated by South Nassau Communities Hospital, a 455-bed not-for-profit teaching hospital in Oceanside – and those who do risk spreading the disease, which in rare cases can prove fatal. According to the South Nassau Truth in Medicine Poll – in which independent…


Some pig: USDA, Codagenix target swine flu

By GREGORY ZELLER // With Zika virus, Foot and Mouth Disease and other global threats already in its crosshairs, Farmingdale biotech Codagenix Inc. is challenging another high-profile opponent: swine flu. A Phase I Small Business Innovation Research grant from the U.S. Department of Agriculture will fund research and development of an influenza vaccine for swine using Codagenix’s proprietary software platform, which “re-codes” viruses to create and test potential vaccines. Research and development under the $99,710…